XML 78 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Condensed Financial Information of Registrant Condensed Financial Information of Registrant
The condensed balance sheets as of December 31, 2019 and 2018, and the related condensed statements of operations, comprehensive income (loss) and cash flows for each of the three years in the period ended December 31, 2019 for our parent company Molina Healthcare, Inc. (the “Registrant”), are presented below.
Condensed Balance Sheets
 
December 31,
 
2019
 
2018
 
(In millions, except per-share data)
ASSETS
Current assets:
 

 
 
Cash and cash equivalents
$
836

 
$
70

Investments
161

 
100

Receivables
2

 
2

Due from affiliates
49

 
90

Prepaid expenses and other current assets
46

 
47

Derivative asset
29

 
476

Total current assets
1,123

 
785

Property, equipment, and capitalized software, net
327

 
176

Goodwill and intangible assets, net
13

 
13

Investments in subsidiaries
2,225

 
2,768

Deferred income taxes
10

 
39

Advances to related parties and other assets
76

 
40

Total assets
$
3,774

 
$
3,821

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Medical claims and benefits payable
$

 
$
4

Accounts payable and accrued liabilities
260

 
223

Current portion of long-term debt
18

 
241

Derivative liability
29

 
476

Total current liabilities
307

 
944

Long-term debt
1,237

 
1,020

Finance lease liabilities
231

 
197

Other long-term liabilities
39

 
13

Total liabilities
1,814

 
2,174

Stockholders’ equity:
 
 
 
Common stock, $0.001 par value; 150 million shares authorized; outstanding: 62 million shares at each of December 31, 2019, and December 31, 2018

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

Additional paid-in capital
175

 
643

Accumulated other comprehensive income (loss)
4

 
(8
)
Retained earnings
1,781

 
1,012

Total stockholders’ equity
1,960

 
1,647

Total liabilities and stockholders’ equity
$
3,774

 
$
3,821


See accompanying notes.
Condensed Statements of Operations
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
(In millions)
Revenue:
 
 
 
 
 
Administrative services fees
$
1,038

 
$
1,138

 
$
1,317

Investment income and other revenue
18

 
17

 
16

Total revenue
1,056

 
1,155

 
1,333

Expenses:
 
 
 
 
 

General and administrative expenses
937

 
1,007

 
1,082

Depreciation and amortization
63

 
69

 
93

Other operating expenses

 
8

 
16

Restructuring costs
4

 
35

 
153

Impairment losses

 

 
39

Total operating expenses
1,004

 
1,119

 
1,383

Gain on sale of subsidiary

 
37

 

Operating income (loss)
52

 
73

 
(50
)
Interest expense
87

 
114

 
117

Other (income) expense, net
(15
)
 
17

 
(61
)
Loss before income tax (benefit) expense and equity in net earnings (losses) of subsidiaries
(20
)
 
(58
)
 
(106
)
Income tax expense (benefit)
9

 
(14
)
 
8

Net loss before equity in net earnings (losses) of subsidiaries
(29
)
 
(44
)
 
(114
)
Equity in net earnings (losses) of subsidiaries
766

 
751

 
(398
)
Net income (loss)
$
737

 
$
707

 
$
(512
)

Condensed Statements of Comprehensive Income (Loss)
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
(In millions)
Net income (loss)
$
737

 
$
707

 
$
(512
)
Other comprehensive income (loss):
 
 
 
 
 
Unrealized investment income (loss)
16

 
(3
)
 
(5
)
Less: effect of income taxes
4

 
(1
)
 
(2
)
Other comprehensive income (loss), net of tax
12

 
(2
)
 
(3
)
Comprehensive income (loss)
$
749

 
$
705

 
$
(515
)

See accompanying notes.

Condensed Statements of Cash Flows
 
Year Ended December 31,
 
2019
 
2018
 
2017
 
(In millions)
Operating activities:
 
 
 
 
 
Net cash provided by operating activities
$
64

 
$
118

 
$
166

Investing activities:
 
 
 
 
 

Capital contributions to subsidiaries
(43
)
 
(145
)
 
(370
)
Dividends received from subsidiaries
1,373

 
298

 
286

Purchases of investments
(152
)
 
(136
)
 
(331
)
Proceeds from sales and maturities of investments
93

 
388

 
156

Purchases of property, equipment and capitalized software
(56
)
 
(22
)
 
(67
)
Net cash received from sale of subsidiaries

 
242

 

Change in amounts due to/from affiliates
38

 
6

 
(49
)
Other, net
1

 

 

Net cash provided by (used in) investing activities
1,254

 
631

 
(375
)
Financing activities:
 
 
 
 
 

Repayment of principal amount of convertible notes
(240
)
 
(362
)
 

Cash paid for partial settlement of conversion option
(578
)
 
(623
)
 

Cash received for partial settlement of call option
578

 
623

 

Cash paid for partial termination of warrants
(514
)
 
(549
)
 

Proceeds from borrowings under term loan facility
220

 

 

Common stock purchases
(47
)
 

 

Repayment of credit facility

 
(300
)
 

Proceeds from senior notes offerings, net of issuance costs

 

 
325

Proceeds from borrowings under credit facility

 

 
300

Other, net
29

 
19

 
11

Net cash (used in) provided by financing activities
(552
)
 
(1,192
)
 
636

Net (decrease) increase in cash and cash equivalents
766

 
(443
)
 
427

Cash and cash equivalents at beginning of period
70

 
513

 
86

Cash and cash equivalents at end of period
$
836

 
$
70

 
$
513


Notes to Condensed Financial Information of Registrant
Note A - Basis of Presentation
The Registrant was incorporated in 2002. Prior to that date, Molina Healthcare of California (formerly known as Molina Medical Centers) operated as a California health plan and as the parent company for three other state health plans. In June 2003, the employees and operations of the corporate entity were transferred from Molina Healthcare of California to the Registrant.
The Registrant’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since the date of acquisition. The accompanying condensed financial information of the Registrant should be read in conjunction with the consolidated financial statements and accompanying notes.
Note B - Transactions with Subsidiaries
The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care management services, human resources, marketing, purchasing, risk management, actuarial, underwriting, finance, accounting, legal and public
relations. Fees are based on the fair market value of services rendered and are recorded as operating revenue. Payment is subordinated to the subsidiaries’ ability to comply with minimum capital and other restrictive financial requirements of the states in which they operate. Charges in 2019, 2018, and 2017 for these services amounted to $1,038 million, $1,137 million, and $1,317 million, respectively, and are included in operating revenue.
The Registrant and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Registrant. Income taxes are allocated to each subsidiary in accordance with an intercompany tax allocation agreement. The agreement allocates income taxes in an amount generally equivalent to the amount which would be expensed by the subsidiary if it filed a separate tax return. Net operating loss benefits are paid to the subsidiary by the Registrant to the extent such losses are utilized in the consolidated tax returns.
Note C - Dividends and Capital Contributions
When the Registrant receives dividends from its subsidiaries, such amounts are recorded as a reduction to the investments in the respective subsidiaries.
For all periods presented, the Registrant made capital contributions to certain subsidiaries primarily to comply with minimum net worth requirements and to fund business combinations. Such amounts have been recorded as an increase in investment in the respective subsidiaries.